跳至主要内容
临床试验/NCT04796285
NCT04796285
进行中(未招募)
不适用

A Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk Monitor

Brigham and Women's Hospital1 个研究点 分布在 1 个国家目标入组 6 人2022年8月1日

概览

阶段
不适用
干预措施
Lab Clasp
疾病 / 适应症
Sepsis
发起方
Brigham and Women's Hospital
入组人数
6
试验地点
1
主要终点
Comparison of average difference lactate readings between Lab Clasp and laboratory reference values.
状态
进行中(未招募)
最后更新
2个月前

概览

简要总结

The overall purpose of this study is to demonstrate the usability of a clinical-grade device in the form of a finger clasp similar to a pulse oximeter for monitoring lactate values, by comparing its performance in reading interstitial fluid lactate values against a known clinical standard in the form of venous lactate levels.

Serum lactate measurements are used clinically as a measure of end-organ dysfunction and physiologic stress. Changes in lactate may indicate worsening infection in the setting of sepsis, drug toxicity for certain xenobiotics, or exercise tolerance in exercise physiology. Serum lactate cutoffs have been developed for various disease states and trigger a variety of medical decisions directed at managing the course of the disease.

A common theme in the application of lactate measurements to understanding changes in physiology is the need to obtain venous blood to determine lactate. While point-of-care assays have been developed that improve the processing speed, there continues to be a need to obtain fingerstick blood or in most cases, venous blood. Obtaining venous blood for serum lactate requires an individual with phlebotomy skills, the processing capabilities of a laboratory to determine lactate concentrations, or the availability of point of care technology.

An alternative method to measure lactate is to sample interstitial fluid which surrounds cells and tissues in the body. Obtaining interstitial fluid is potentially less invasive without the need for repeat phlebotomy or the presence of an indwelling intravenous catheter which can become complicated by infection. The analysis of interstitial fluid for glucose has been validated and is clinically utilized in continuous glucose monitors in individuals with diabetes. In this investigation, the investigators will utilize a novel device, the Lab Clasp to obtain interstitial fluid in a noninvasive method. The Lab Clasp is manufactured to resemble a finger pulse oximeter with additional onboard microfluidics channels that obtain a lactate concentration from interstitial fluid. This streamlined process of obtaining the point of care lactate measurements on demand allows for tasks like serial lactate measurements to be accomplished on a reliable schedule with less workload for nursing staff typically required to draw venous blood. Additionally, the portable and noninvasive nature of the Lab Clasp system may render it usable in facilities that lack skilled staff necessary to perform phlebotomy.

注册库
clinicaltrials.gov
开始日期
2022年8月1日
结束日期
2026年8月1日
最后更新
2个月前
研究类型
Interventional
研究设计
Single Group
性别
All

研究者

责任方
Principal Investigator
主要研究者

Guruprasad Jambaulikar, MBBS, MPH

Director of Research, Emergency Medicine

Brigham and Women's Hospital

入排标准

入选标准

  • Are 18 years or older
  • In general good health, evidenced by no unstable medical problems (no medication changes in the past 3 months)
  • Have no known skin allergy to the components of the Lab Clasp
  • Willing to comply with all study procedures including providing venous blood samples at the CCI
  • Are English speaking
  • Provide consent to participate in the study

排除标准

  • Individuals \<18 years old
  • General frailty of health
  • Prohibitively poor vascular access
  • History of malignancy or active malignancy
  • History of cardiac illness
  • History of HIV on antiretrovirals
  • History of alcohol abuse
  • History of uncontrolled psychiatric illness
  • Recent hospitalization within the past 30 days
  • History of vaping, propylene glycol use

研究组 & 干预措施

Lab Clasp

A finger based device to assay interstitial fluid lactate

干预措施: Lab Clasp

结局指标

主要结局

Comparison of average difference lactate readings between Lab Clasp and laboratory reference values.

时间窗: 150 minutes

The primary outcome measure will be the average difference in lactate values between the Lab Clasp device and the reference (laboratory venous lactate) in healthy volunteers. We will obtain multiple (nine timepoints in total) investigational-reference measurement pairs in each subject (150 minutes total) and will average the difference over all pairs from all subjects.

次要结局

  • Measurement of participant experience(150 minutes)

研究点 (1)

Loading locations...

相似试验